Cell sorting is a technique to separate cells on the basis of their intracellular and extracellular properties that is used in various research and medicinal applications. Cell sorting instruments are equipped with advanced features and functionalities to carry out various clinical studies. The global cell sorting market size was worth $ XX billion in 2018 and is forecasted to reach $ XX billion by 2026, at a CAGR of XX% during the forecast period (2019-2026).
The global cell sorting market is growing due to rising prevalence of cancer. For instance, according to a recent study (2018) by American Cancer Society epidemiologists, there were about 42% of newly cancers diagnosed in the US (about 729,000 cases in 2018). The incidence of all cancer types worldwide is anticipated to increase at a CAGR of 2.5% during 2015-2030. Many of these cancers are to go for Cell Sorting as part of their cancer treatments. For instance, in May 2019, with the rise of cancer cases every year, the first Halcyon Cell Sorting machine in South-East Asia to treat this deadly disease has been installed in a private hospital in Malaysia. In addition, technological advancement in cell sorters is also driving the growth of the cell sorting market globally. For instance, in May 2018, BD (Becton, Dickinson and Company), launched the BD FACSymphony S6 cell sorter. The new platform leverages the high parameter capabilities of the BD FACSymphony cell analyzer, giving researchers the ability to sort cell populations to better understand cell phenotypes for immunology and multi-omics research. Also, growing adoption of cell sorter techniques in clinical and research application, increasing funding and investments for the development of innovative cell sorting techniques are some of the other major factors driving the growth of the cell sorting market globally. In June 2018, ThinkCyte, Inc., a company focusing on developing a high-throughput imaging-activated cell sorting system, completed a US$3.2 million (JPY 350 million) seed-financing round. ThinkCytes novel Ghost Cytometry method uses a proprietary combination of ghost motion imaging, microfluidics, and machine-learning to image and sort single-cells. However, high cost of instrument and lack of awareness towards cell sorting technology in developing countries are some of the factors hindering the growth of the cell sorting market. For instance, cell sorting treatments on the machine would cost between US$ 716.92 (RM 3,000) to US$ 5974.38 (RM 25,000), depending on the treatment prescribed.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: